The overnight sell-off in the tech-heavy Nasdaq Composite dampened domestic investors’ sentiment, who track cues from the mother market….Read More
Venus Remedies announced that its investigational product VRP-034 has been granted Qualified Infections Disease Product (QIDP) designation by the United States Food and Drug Administration (USFDA) for the traeatment of bloodstream infections caused by polymyxin B (PMB) susceptible stains in adults.
The Sensex was down 36.97 points or 0.05 percent at 77,007.32, and the Nifty was down 36.05 points or 0.15 percent at 23,401.15. About 1708 shares advanced, 1293 shares declined, and 145 shares unchanged.
| Company | CMP Chg(%) | Today Vol 5D Avg Vol | Vol Chg(%) |
|---|---|---|---|
| LIQUIDBETF | 1,026.52 | 163.17k 1,455.20 |
11,113.00 |
| Sky Gold | 350.35 | 1.69m 25,988.60 |
6,417.00 |
| SecMark Consult | 124.29 | 59.82k 2,848.60 |
2,000.00 |
| Archidply Decor | 117.95 | 157.78k 9,131.20 |
1,628.00 |
| Soma Textile | 51.60 | 644.28k 81,439.60 |
691.00 |
| Cello World | 585.30 | 615.63k 82,394.60 |
647.00 |
| Binani Ind | 23.11 | 204.37k 29,137.80 |
601.00 |
| Lagnam Spintex | 130.56 | 269.27k 43,750.80 |
515.00 |
| Cellecor | 49.35 | 3.43m 562,800.00 |
509.00 |
| BEW Eng | 199.75 | 5.50k 1,125.00 |
389.00 |
India’s largest pure-play credit card issuer has signed a partnership with Tata Digital to launch the Tata Neu SBI Card, aiming to provide a premium and highly rewarding shopping experience for customers across various segments.
The cautious global sentiment may pose headwinds to the Wipro’s growth prospects in FY26, noted brokerages….Read More
The Board has approved the appointment of Alok Prakash as Chief Executive Officer of the company, effective April 16.
Vijay Shekhar Sharma, Chairman, Managing Director, and CEO of the company, has voluntarily forgone all 2.1 crore ESOPs granted to him under the One 97 Employees Stock Option Scheme, 2019, with immediate effect. This will result in a one-time, non-cash acceleration of ESOP expense amounting to Rs 492 crore in Q4 FY25, with an equivalent reduction in ESOP expenses in future years.
The company has announced a temporary production pause from April 17 to 19 at four of its manufacturing plants—Dharuhera, Gurugram, Haridwar, and Neemrana—due to a short-term supply alignment. Production will resume on April 21. Its Tirupati and Halol plants will continue to operate during this period. The pause will not impact the company’s ability to meet retail demand in domestic or international markets. Any production deferment will be efficiently recovered in the following month.
#1 IT services revenues declined 0.8 percent QoQ, below estimate
#2 Margin of 17.1 percent was below the estimate of 17.5 percent
#3 Q1 FY26 revenue growth guidance is -3.5 percent to -1.5 percent QoQ in CC terms, below the estimate of -2 percent to 0 percent
#4 TCV of USD 4 billion was in-line, with a mix gravitating towards large deals
#5 TCV showed 83.5 percent YoY growth
#6 All other verticals showed a QoQ decline
#7 In terms of geography, APMEA led growth
Infosys, HDFC Life Insurance Company, HDFC Asset Management Company, Jio Financial Services, Tata Elxsi, Mahindra EPC Irrigation, Indosolar, and National Standard (India) will release their quarterly earnings on April 17.